Track COSCIENS Biopharma's total liabilities ($20M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
COSCIENS Biopharma (CSCI) currently reports a total liabilities of $20M as of June 2025. That compares with $24M in the prior-year period — down 14.1% year over year. Use the charts on this page to explore COSCIENS Biopharma's total liabilities history and peer comparisons.
COSCIENS Biopharma's total liabilities decreased from $24M to $20M — a 14.1% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
COSCIENS Biopharma reported $20M in total liabilities as of June 2025. That compares with $24M in the prior-year period — down 14.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following CSCI for alerts when major investors trade the stock.